Efficacy and safety of botulinum toxin injection in reducing deltoid muscle hypertrophy.
aesthetic medicine
body contouring
botulinum toxin
deltoid muscle
muscle hypertrophy
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
28
09
2021
received:
17
12
2020
accepted:
19
10
2021
pubmed:
23
10
2021
medline:
2
4
2022
entrez:
22
10
2021
Statut:
ppublish
Résumé
With the increasing demand for body contouring, botulinum toxin (BTX) injection is being widely used off-label for muscular hypertrophy. However, to the best of our knowledge, no study has investigated the clinical efficacy of BTX type A (BTX-A) in deltoid muscle hypertrophy. This study was conducted to evaluate the efficacy and safety of intramuscular injection of BTX in reducing deltoid muscle hypertrophy. Overall, 10 patients with bilateral deltoid muscle hypertrophy were treated with an intramuscular injection of prabotulinum toxin A, with a total of 50 units [U] administered per patient. As measured by ultrasonography, the thickness of the deltoid muscles was significantly decreased at weeks 2 and 12. In addition, the clinical assessment score by blinded investigators was improved after the treatment; however, patients' satisfaction scores were relatively low. No major complications were reported. Therefore, intramuscular injection of BTX-A seems to be a candidate for novel treatment option for deltoid muscle hypertrophy. Further larger clinical studies are warranted to confirm the efficacy of BTX-A.
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15168Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Bogari M, Tan A, Xin Y, et al. Treatment of gastrocnemius muscle hypertrophy with botulinum toxin injection followed by magnetic resonance imaging assessment and 3-dimensional evaluation. Aesthet Surg J. 2017;37(10):1146-1156.
Wanitphakdeedecha R, Ungaksornpairote C, Kaewkes A, Sathaworawong A, Vanadurongwan B, Lektrakul N. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. J Cosmet Dermatol. 2018;17(6):984-990.
Suh Y, Jeong GJ, Noh H, et al. A multicenter, randomized, open-label comparative study of prabotulinumtoxin A with two different dosages and diverse proportional injection styles for the reduction of gastrocnemius muscle hypertrophy in Asian women. Dermatol Ther. 2019;32(5):e13009.
Oh WJ, Kwon TR, Oh CT, Kim YS, Kim BJ. Clinical application of botulinum toxin a for calf hypertrophy followed by 3-dimensional computed tomography. Plast Reconstr Surg Glob Open. 2018;6(2):e1071.
Lee HJ, Lee DW, Park YH, Cha MK, Kim HS, Ha SJ. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg. 2004;30(6):867-871. discussion 871.
Han KH, Joo YH, Moon SE, Kim KH. Botulinum toxin A treatment for contouring of the lower leg. J Dermatolog Treat. 2006;17(4):250-254.
Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994;93(5):913-918.
Cheng J, Chung HJ, Friedland M, Hsu SH. Botulinum toxin injections for leg contouring in east Asians. Dermatol Surg. 2020;46(Suppl 1):S62-S70.
Cheng J, Hsu SH, McGee JS. Botulinum toxin injections for masseter reduction in east Asians. Dermatol Surg. 2019;45(4):566-572.
Kim NH, Chung JH, Park RH, Park JB. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg. 2005;115(3):919-930.
To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 2001;54(3):197-200.
Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg. 2003;29(5):484-489.